BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, Sofian M, Adibi L, Irani N, Mehryar M, Akbari HM, Purkhayat SM, Ramezani A. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis 2009;13:685-9. [PMID: 19138545 DOI: 10.1016/j.ijid.2008.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ansari N, Makvandi M, Samarbaf-Zadeh AR. Hepatitis B virus genotyping among patients with cirrhosis. Jundishapur J Microbiol. 2015;8:e14571. [PMID: 25964845 DOI: 10.5812/jjm.14571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Du L, Liu M, Liu M, Zhou T, Cheng X, Liu C, Tang H. The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant. Biomed Res Int 2017;2017:8415907. [PMID: 28713830 DOI: 10.1155/2017/8415907] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Antaki N, Haffar S, Ali Deeb S, Assaad F, Abou Harb R, Zeibane N, Nasserelddine M, Ibrahim N, Alhaj N, Jabbour E, Aaraj R, Antaki F, Kebbewar K; Syrian Working Group for the Study of Viral Hepatitis. High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. Epidemiol Infect 2010;138:40-4. [PMID: 19538827 DOI: 10.1017/S0950268809990288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Haghshenas MR, Arabi M, Mousavi T. Hepatitis B genotypes in iran. Mater Sociomed 2014;26:129-33. [PMID: 24944540 DOI: 10.5455/msm.2014.26.129-133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, Sofian M, Ahmadi F, Razeghi E, Eslamifar A. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis. 2010;66:285-291. [PMID: 19903586 DOI: 10.1016/j.diagmicrobio.2009.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
7 Makvandi M, Neisi N, Khalafkhany D, Makvandi K, Hajiani E, Shayesteh AA, Masjedi Zadeh A, Sina AH, Hamidifard M, Rasti M. Occult hepatitis B virus among the patients with abnormal alanine transaminase. Jundishapur J Microbiol. 2014;7:e11648. [PMID: 25485052 DOI: 10.5812/jjm.11648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
9 Vaezjalali M, Rezaee H, Goudarzi H. HBV S Gene Premature Stop Codon in Strains From Middle Eastern Patients. Arch Clin Infect Dis 2012;8:3-7. [DOI: 10.5812/archcid.14410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2015;7:e22674. [PMID: 25738121 DOI: 10.5812/numonthly.22674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, Foroughi M, Ahmadi F, Eslamifar A, Sadat SM, Ramezani A. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis. Hepat Mon 2013;13:e7481. [PMID: 23914228 DOI: 10.5812/hepatmon.7481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Abedi-Ardekani B, Gouas D, Villar S, Sotoudeh M, Hainaut P. TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations. Hepat Res Treat 2011;2011:475965. [PMID: 21869931 DOI: 10.1155/2011/475965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
13 Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-10. [PMID: 19656713 DOI: 10.1016/j.ijid.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
14 Zaky S, Farghaly AM, Rashed H, Hassan H, Faouzy E, Makhlouf N, Hussein MRA. Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt. Cellular Immunology 2010;265:97-104. [DOI: 10.1016/j.cellimm.2010.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Ansari MHK, Rasmi Y, Abbasi L. Hepatitis B virus Genotypes in West Azarbayjan Province, Northwest Iran. Open Access Maced J Med Sci 2017;5:875-9. [PMID: 29362612 DOI: 10.3889/oamjms.2017.206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]